CDK ASSOCIATES, L.L.C. 4
4 · Strongbridge Biopharma plc · Filed Jul 23, 2018
Insider Transaction Report
Form 4
CDK ASSOCIATES, L.L.C.
10% Owner
Transactions
- Purchase
Ordinary Shares, $0.01 par value
2018-07-23$4.95/sh+20,400$100,980→ 5,464,734 total - Purchase
Ordinary Shares, $0.01 par value
2018-07-20$4.97/sh+21,100$104,795→ 5,444,334 total - Purchase
Ordinary Shares, $0.01 par value
2018-07-19$4.98/sh+14,000$69,747→ 5,423,234 total
Footnotes (1)
- [F1]These shares represent (a) 5,169,133 Ordinary Shares that are owned directly by CDK Associates, LLC, which is a reporting person, and may be deemed to be indirectly beneficially owned by (i) Caxton Corporation, the manager of CDK Associates, LLC, and (ii) Bruce Kovner, the chairman and sole shareholder of Caxton Corporation; and (b) 295,601 Ordinary Shares beneficially owned by employees of an affiliate of Caxton Corporation and may be deemed to be indirectly beneficially owned by (i) Caxton Corporation and (ii) Bruce Kovner, the chairman and sole shareholder of Caxton Corporation. Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.